Rationale for a nanomedicine approach to thrombolytic therapy
Stroke
.
2010 Oct;41(10 Suppl):S42-4.
doi: 10.1161/STROKEAHA.110.598656.
Authors
Gregory M Lanza
1
,
Jon N Marsh
,
Grace Hu
,
Michael J Scott
,
Anne H Schmieder
,
Shelton D Caruthers
,
Dipanjan Pan
,
Samuel A Wickline
Affiliation
1
Department of Medicine, Division of Cardiology, 4320 Forest Park Ave, Suite 101, St Louis, MO 63108, USA. greg@cvu.wustl.edu
PMID:
20876503
PMCID:
PMC2953722
DOI:
10.1161/STROKEAHA.110.598656
No abstract available
Publication types
Research Support, N.I.H., Extramural
Review
MeSH terms
Brain Ischemia / therapy*
Humans
Nanomedicine
Stroke / therapy*
Thrombolytic Therapy / methods*
Grants and funding
R01NS059302/NS/NINDS NIH HHS/United States
R01HL094470/HL/NHLBI NIH HHS/United States
R01 HL094470/HL/NHLBI NIH HHS/United States
R01 NS059302/NS/NINDS NIH HHS/United States
U54 CA119342/CA/NCI NIH HHS/United States